825 followers
[LIVER] Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with… https://t.co/TmdAL6AoSP
[LIVER] Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with… https://t.co/TmdAL6AoSP
Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with ch... http://t.co/tDPHitcSOD